Clinical Trial: NCT05838066
Efficacy and Safety of KN026 in Combination With HB1801 in the First-line Treatment of Subjects With HER2-positive Recurrent or Metastatic Breast Cancer.
Status:
RECRUITINGPhase:
Phase 3| Lead Sponsor: | Shanghai JMT-Bio Inc. |
| Information Provided By: | Shanghai JMT-Bio Inc. |
| Last Update Posted: | 2025-05-30 |
Study Overview
Brief Summary
This is a randomized, controlled, open-label, multicenter, phase Ш clinical study designed to compare the efficacy and safety of KN026 in combination with HB1801 to trastuzumab in combination with pertuzumab and docetaxel in the first-line treatment of subjects with HER2-positive recurrent or metastatic breast cancer. The statistical assumption for this study is superiority. The primary study endpoint was PFS as assessed by Blinded Independ Review Committee (BIRC).
Official Title
Conditions
Intervention / Treatment
- Drug: Recombinant Humanized Bispecific antibody against HER2,KN026
- Drug: HB1801
- Drug: Pertuzumab
- Drug: Trastuzumab
- Drug: Docetaxel
Other Study ID Numbers
- KN026-003
Start Date (Actual)
Primary Completion Date (Estimated)
Study Completion Date (Estimated)
Enrollment (Estimated)
Study Type
Phase
| Lead Sponsor: | Shanghai JMT-Bio Inc. |
| Information Provided By: | Shanghai JMT-Bio Inc. |
| Last Update Posted: | 2025-05-30 |
Study Overview
Brief Summary
This is a randomized, controlled, open-label, multicenter, phase Ш clinical study designed to compare the efficacy and safety of KN026 in combination with HB1801 to trastuzumab in combination with pertuzumab and docetaxel in the first-line treatment of subjects with HER2-positive recurrent or metastatic breast cancer. The statistical assumption for this study is superiority. The primary study endpoint was PFS as assessed by Blinded Independ Review Committee (BIRC).
Official Title
Conditions
Intervention / Treatment
- Drug: Recombinant Humanized Bispecific antibody against HER2,KN026
- Drug: HB1801
- Drug: Pertuzumab
- Drug: Trastuzumab
- Drug: Docetaxel
Other Study ID Numbers
- KN026-003